Effects and mechanisms of innate immune molecules on inhibiting nasopharyngeal carcinoma.
作者信息
Xiong Fang, Deng Su, Huang Hong-Bin, Li Xia-Yu, Zhang Wen-Ling, Liao Qian-Jin, Ma Jian, Li Xiao-Ling, Xiong Wei, Li Gui-Yuan, Zeng Zhao-Yang, Guo Can
机构信息
Science and Technology on Information System Engineering Laboratory, National University of Defense Technology, Changsha, Hunan 410000, China.
Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Xiangya Hospital, Central South University, Changsha, Hunan 410078, China.
出版信息
Chin Med J (Engl). 2019 Mar 20;132(6):749-752. doi: 10.1097/CM9.0000000000000132.
Abstract
摘要
相似文献
1
Effects and mechanisms of innate immune molecules on inhibiting nasopharyngeal carcinoma.天然免疫分子抑制鼻咽癌的作用及机制
Chin Med J (Engl). 2019 Mar 20;132(6):749-752. doi: 10.1097/CM9.0000000000000132.
2
Exosomes derived from nasopharyngeal carcinoma cells induce IL-6 production from macrophages to promote tumorigenesis.源自鼻咽癌细胞的外泌体可诱导巨噬细胞产生白细胞介素-6，从而促进肿瘤发生。
Cell Mol Immunol. 2021 Feb;18(2):501-503. doi: 10.1038/s41423-020-0420-0. Epub 2020 Apr 1.
3
BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM.BPIFB1（LPLUNC1）通过与 VTN 和 VIM 相互作用抑制鼻咽癌细胞的迁移和侵袭。
Br J Cancer. 2018 Jan;118(2):233-247. doi: 10.1038/bjc.2017.385. Epub 2017 Nov 9.
4
New insights on the palate, lung, and nasal epithelium clone (PLUNC) proteins: Based on molecular and functional analysis of its homolog of YH1/SPLUNC1.腭、肺和鼻上皮克隆（PLUNC）蛋白的新见解：基于其YH1/SPLUNC1同源物的分子和功能分析。
Exp Mol Pathol. 2016 Jun;100(3):363-9. doi: 10.1016/j.yexmp.2015.12.002. Epub 2015 Dec 3.
5
Transcriptome Related to Avoiding Immune Destruction in Nasopharyngeal Cancer in Indonesian Patients Using Next-Generation Sequencing.基于下一代测序的印尼鼻咽癌患者避免免疫破坏的转录组研究。
Asian Pac J Cancer Prev. 2020 Sep 1;21(9):2593-2601. doi: 10.31557/APJCP.2020.21.9.2593.
6
Topoisomerase IIa deregulation in nasopharyngeal carcinoma.鼻咽癌中拓扑异构酶IIa的失调
J BUON. 2019 Jul-Aug;24(4):1736.
7
The immunologic advantage of recurrent nasopharyngeal carcinoma from the viewpoint of Galectin-9/Tim-3-related changes in the tumour microenvironment.从肿瘤微环境中 Galectin-9/Tim-3 相关变化的角度看复发性鼻咽癌的免疫优势。
Sci Rep. 2017 Sep 4;7(1):10349. doi: 10.1038/s41598-017-10386-y.
8
Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms.乳铁传递蛋白通过多种机制抑制 AKT，从而在鼻咽癌中发挥肿瘤抑制作用。
Oncogene. 2013 Sep 5;32(36):4273-83. doi: 10.1038/onc.2012.434. Epub 2012 Oct 15.
9
Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.放射性治疗引发的抗肿瘤免疫反应和免疫相关不良反应在一例接受抗 PD-1 免疫治疗的复发性鼻咽癌病例中。
BMC Cancer. 2018 Apr 6;18(1):395. doi: 10.1186/s12885-018-4295-8.
10
[The specific immunophenotypic features of nasopharyngeal carcinoma].[鼻咽癌的特定免疫表型特征]
Vestn Otorinolaringol. 2018;83(5):40-44. doi: 10.17116/otorino20188305140.
引用本文的文献
1
Micropeptides: potential treatment strategies for cancer.微小肽：癌症的潜在治疗策略
Cancer Cell Int. 2024 Apr 15;24(1):134. doi: 10.1186/s12935-024-03281-w.
2
BPIFB1 promotes metastasis of hormone receptor-positive breast cancer via inducing macrophage M2-like polarization.BPIFB1 通过诱导巨噬细胞 M2 样极化促进激素受体阳性乳腺癌的转移。
Cancer Sci. 2023 Nov;114(11):4157-4171. doi: 10.1111/cas.15957. Epub 2023 Sep 13.
3
Clinical prospects and research strategies of long non-coding RNA encoding micropeptides.长非编码 RNA 编码小肽的临床前景与研究策略。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023 Aug 25;52(4):397-405. doi: 10.3724/zdxbyxb-2023-0128.
4
FAM201A encodes small protein NBASP to inhibit neuroblastoma progression via inactivating MAPK pathway mediated by FABP5.FAM201A 通过编码小蛋白 NBASP 抑制神经母细胞瘤的进展，其作用机制为通过 FABP5 使 MAPK 通路失活。
Commun Biol. 2023 Jul 12;6(1):714. doi: 10.1038/s42003-023-05092-7.
5
Tanshinone-IIA mediated neuroprotection by modulating neuronal pathways.丹参酮 IIA 通过调节神经元通路介导的神经保护作用。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Aug;396(8):1647-1667. doi: 10.1007/s00210-023-02476-8. Epub 2023 Apr 3.
6
Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV.关于 Epstein-Barr 病毒（EBV）相关的鼻咽癌：重点介绍 EBV 的潜伏基因产物。
Medicina (Kaunas). 2022 Dec 20;59(1):2. doi: 10.3390/medicina59010002.
7
Construction of a lncRNA-mRNA Co-Expression Network for Nasopharyngeal Carcinoma.鼻咽癌长链非编码RNA-信使核糖核酸共表达网络的构建
Front Oncol. 2022 Jul 7;12:809760. doi: 10.3389/fonc.2022.809760. eCollection 2022.
8
Epstein-Barr Virus-Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1. Epstein-Barr 病毒编码的环状 RNA CircBART2.2 通过调节 PD-L1 促进鼻咽癌的免疫逃逸。
Cancer Res. 2021 Oct 1;81(19):5074-5088. doi: 10.1158/0008-5472.CAN-20-4321. Epub 2021 Jul 28.
9
Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma.甲状腺乳头状癌中免疫相关预后特征及关键基因的鉴定与验证
Cancer Cell Int. 2021 Jul 15;21(1):378. doi: 10.1186/s12935-021-02066-9.
10
What are the applications of single-cell RNA sequencing in cancer research: a systematic review.单细胞 RNA 测序在癌症研究中的应用：系统评价。
J Exp Clin Cancer Res. 2021 May 11;40(1):163. doi: 10.1186/s13046-021-01955-1.
本文引用的文献
1
Effects of tumor metabolic microenvironment on regulatory T cells.肿瘤代谢微环境对调节性 T 细胞的影响。
Mol Cancer. 2018 Nov 26;17(1):168. doi: 10.1186/s12943-018-0913-y.
2
The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma.爱泼斯坦-巴尔病毒编码的微小RNA在鼻咽癌中的新作用。
J Cancer. 2018 Jul 30;9(16):2852-2864. doi: 10.7150/jca.25460. eCollection 2018.
3
Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.通过全基因组测序鉴定鼻咽癌和鼻咽癌衍生的 Epstein-Barr 病毒中的基因组改变。
Carcinogenesis. 2018 Dec 31;39(12):1517-1528. doi: 10.1093/carcin/bgy108.
4
BPIFB1 (LPLUNC1) inhibits radioresistance in nasopharyngeal carcinoma by inhibiting VTN expression.BPIFB1（LPLUNC1）通过抑制 VTN 表达抑制鼻咽癌的放射抵抗性。
Cell Death Dis. 2018 Apr 1;9(4):432. doi: 10.1038/s41419-018-0409-0.
5
Human T-cell immunity against the emerging and re-emerging viruses.人类针对新兴和重现病毒的 T 细胞免疫。
Sci China Life Sci. 2017 Dec;60(12):1307-1316. doi: 10.1007/s11427-017-9241-3. Epub 2017 Nov 29.
6
BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM.BPIFB1（LPLUNC1）通过与 VTN 和 VIM 相互作用抑制鼻咽癌细胞的迁移和侵袭。
Br J Cancer. 2018 Jan;118(2):233-247. doi: 10.1038/bjc.2017.385. Epub 2017 Nov 9.
7
STING-mediated DNA sensing in cancer immunotherapy.STING 介导的 DNA 传感在癌症免疫治疗中的作用。
Sci China Life Sci. 2017 Jun;60(6):563-574. doi: 10.1007/s11427-016-9066-0. Epub 2017 May 29.
8
Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src/FAK-involved pathway.石蒜碱通过诱导细胞凋亡和阻断 Src/FAK 通路抑制乳腺癌的生长和转移。
Sci China Life Sci. 2017 Apr;60(4):417-428. doi: 10.1007/s11427-016-0368-y. Epub 2017 Feb 27.
9
Genome-wide Analysis of Epstein-Barr Virus (EBV) Integration and Strain in C666-1 and Raji Cells.C666-1和Raji细胞中爱泼斯坦-巴尔病毒（EBV）整合及毒株的全基因组分析
J Cancer. 2016 Jan 1;7(2):214-24. doi: 10.7150/jca.13150. eCollection 2016.
10
Lactoferrin suppresses the Epstein-Barr virus-induced inflammatory response by interfering with pattern recognition of TLR2 and TLR9.乳铁蛋白通过干扰 TLR2 和 TLR9 的模式识别来抑制 Epstein-Barr 病毒诱导的炎症反应。
Lab Invest. 2014 Nov;94(11):1188-99. doi: 10.1038/labinvest.2014.105. Epub 2014 Jul 28.
Zotero 插件